Organic anion transporting polypeptides (OATPs) are uptake transporters for a broad range of endogenous compounds and xenobiotics. To investigate the physiologic and pharmacologic roles of OATPs of the 1A and 1B subfamilies, we generated mice lacking all established and predicted mouse Oatp1a/1b transporters (referred to as Slco1a/1b–/– mice, as SLCO genes encode OATPs). Slco1a/1b–/– mice were viable and fertile but exhibited markedly increased plasma levels of bilirubin conjugated to glucuronide and increased plasma levels of unconjugated bile acids. The unexpected conjugated hyperbilirubinemia indicates that Oatp1a/1b transporters normally mediate extensive hepatic reuptake of glucuronidated bilirubin. We therefore hypothesized that substantial sinusoidal secretion and subsequent Oatp1a/1b-mediated reuptake of glucuronidated compounds can occur in hepatocytes under physiologic conditions. This alters our perspective on normal liver functioning. Slco1a/1b–/– mice also showed drastically decreased hepatic uptake and consequently increased systemic exposure following i.v. or oral administration of the OATP substrate drugs methotrexate and fexofenadine. Importantly, intestinal absorption of oral methotrexate or fexofenadine was not affected in Slco1a/1b–/– mice. Further analysis showed that rifampicin was an effective and specific Oatp1a/1b inhibitor in controlling methotrexate pharmacokinetics. These data indicate that Oatp1a/1b transporters play an essential role in hepatic reuptake of conjugated bilirubin and uptake of unconjugated bile acids and drugs. Slco1a/1b–/– mice will provide excellent tools to study further the role of Oatp1a/1b transporters in physiology and drug disposition.
Evita van de Steeg, Els Wagenaar, Cornelia M.M. van der Kruijssen, Johanna E.C. Burggraaff, Dirk R. de Waart, Ronald P.J. Oude Elferink, Kathryn E. Kenworthy, Alfred H. Schinkel
Title and authors | Publication | Year |
---|---|---|
Drug‐Induced Liver Injury Associated With Emerging Cancer Therapies
Chodup P, Samodelov SL, Visentin M, Kullak\u2010Ublick GA |
Liver International | 2025 |
Rifampin- and Silymarin-mediated Pharmacokinetic Interactions of Exogenous and Endogenous Substrates in a Transgenic OATP1B Mouse Model
Bechtold BJ, Lynch KD, Oyanna VO, Call MR, Graf TN, Oberlies NH, Clarke JD |
Molecular Pharmaceutics | 2024 |
The role of botanical triterpenoids and steroids in bile acid metabolism, transport, and signaling: Pharmacological and toxicological implications
Luo Z, Zhou W, Xie T, Xu W, Shi C, Xiao Z, Si Y, Ma Y, Ren Q, Di L, Shan J |
Acta Pharmaceutica Sinica. B | 2024 |
Risk Variants Associated With Normal Pressure Hydrocephalus: Genome-Wide Association Study in the FinnGen Cohort
Räsänen J, Heikkinen S, Mäklin K, Lipponen A, Kuulasmaa T, Mehtonen J, Korhonen VE, Junkkari A, Grenier-Boley B, Bellenguez C, Oinas M, Avellan C, Frantzén J, Kotkansalo A, Rinne J, Ronkainen A, Kauppinen M, von und zu Fraunberg M, Lönnrot K, Satopää J, Perola M, Koivisto AM, Julkunen V, Portaankorva AM, Mannermaa A, Soininen H, Helisalmi S, Jääskeläinen JE, Lambert JC, Eide PK, Palotie A, Kurki MI, Hiltunen M, Leinonen V |
Neurology | 2024 |
Validation of NBD-coupled taurocholic acid for intravital analysis of bile acid transport in liver and kidney of mice.
Ghallab A, Kunz S, Drossel C, Billo V, Friebel A, Georg M, Göttlich R, Hobloss Z, Hassan R, Myllys M, Seddek AL, Abdelmageed N, Dawson PA, Lindström E, Hoehme S, Hengstler JG, Geyer J |
EXCLI journal | 2024 |
Active Enterohepatic Cycling is Not Required for the Choleretic Actions of 24- Jianing Li, Jennifer K Truong, Kimberly Pachura, Anuradha Rao, Sanjeev Gambeer, Claudia Fuchs, Sau l J Karpen, Michael Trauner, Paul Dawson |
JCI Insight | 2023 |
The kidney drug transporter OAT1 regulates gut microbiome-dependent host metabolism
Jeffry Granados, Vladimir Ermakov, Koustav Maity, David Vera, Geoffrey Chang, Sanjay Nigam |
JCI Insight | 2023 |
Bile Salts by the Back Road.
Oude Elferink RPJ, Van De Graaf SFJ |
Cellular and Molecular Gastroenterology and Hepatology | 2023 |
Fasting‐sensitive SUMO‐switch on Prox1 controls hepatic cholesterol metabolism
Alfaro AJ, Dittner C, Becker J, Loft A, Mhamane A, Maida A, Georgiadi A, Tsokanos F, Klepac K, Molocea C, El\u2010Merahbi R, Motzler K, Geppert J, Karikari RA, Szendrödi J, Feuchtinger A, Hofmann S, Karaca S, Urlaub H, Berriel Diaz M, Melchior F, Herzig S |
EMBO reports | 2023 |
Molecular Mechanisms of Organic Anion Transporting Polypeptide-Mediated Organic Anion Clearance at the Blood-Cerebrospinal Fluid Barrier.
Sun A, Hagenbuch B, Kelly EJ, Wang J |
Molecular pharmacology | 2023 |
Development of a Pharmacokinetic Model That Accounts for the Plasma Concentrations of Conjugated and Unconjugated Bilirubin Observed in a Variety of Disease States
Levitt DG, Levitt MD |
Clinical and experimental gastroenterology | 2023 |
The Hepatic Porphyrias: Revealing the Complexities of a Rare Disease
Balogun O, Nejak-Bowen K |
Seminars in liver disease | 2023 |
The Role of Uptake and Efflux Transporters in the Disposition of Glucuronide and Sulfate Conjugates
E Järvinen, F Deng, W Kiander, A Sinokki, H Kidron, N Sjöstedt |
Frontiers in pharmacology | 2022 |
Serum Bilirubin and Sperm Quality in Adult Population
Chen YY, Chen WL |
Toxics | 2022 |
Drug Transporters ABCB1 (P-gp) and OATP, but not Drug-Metabolizing Enzyme CYP3A4, Affect the Pharmacokinetics of the Psychoactive Alkaloid Ibogaine and its Metabolites
F. Martins ML, Heydari P, Li W, Martínez-Chávez A, Venekamp N, Lebre MC, Lucas L, Beijnen JH, Schinkel AH |
Frontiers in pharmacology | 2022 |
Pharmaceutical strategies for preventing toxicity and promoting antioxidant and anti-inflammatory actions of bilirubin
Nocentini A, Bonardi A, Pratesi S, Gratteri P, Dani C, Supuran CT |
Journal of Enzyme Inhibition and Medicinal Chemistry | 2022 |
Elucidating Mechanisms of Tolerance to Salmonella Typhimurium across Long-Term Infections Using the Collaborative Cross.
Scoggin K, Gupta J, Lynch R, Nagarajan A, Aminian M, Peterson A, Adams LG, Kirby M, Threadgill DW, Andrews-Polymenis HL |
mBio | 2022 |
P-Glycoprotein (MDR1/ABCB1) Restricts Brain Accumulation of the Novel EGFR Inhibitor EAI045 and Oral Elacridar Coadministration Enhances Its Brain Accumulation and Oral Exposure
Wang J, Susam MM, Gan C, Sparidans RW, Lebre MC, Beijnen JH, Schinkel AH |
Pharmaceuticals | 2022 |
Role of Hepatocyte Transporters in Drug-Induced Liver Injury (DILI)—In Vitro Testing
Tátrai P, Erdő F, Krajcsi P |
Pharmaceutics | 2022 |
Distinct Bile Acid Profiles in Patients With Chronic Hepatitis B Virus Infection Reveal Metabolic Interplay Between Host, Virus and Gut Microbiome
Z Sun, C Huang, Y Shi, R Wang, J Fan, Y Yu, Z Zhang, K Zhu, M Li, Q Ni, Z Chen, M Zheng, Z Yang |
Frontiers in Medicine | 2021 |
Toward pharmacogenetic SLCO1B1 ‐guided dosing of methotrexate in arthritis using a murine Slco1b2 knockout model
ZL Taylor, LE Thompson, H Bear, T Mizuno, AA Vinks, LB Ramsey |
Clinical and Translational Science | 2021 |
ABCB1 and ABCG2 Control Brain Accumulation and Intestinal Disposition of the Novel ROS1/TRK/ALK Inhibitor Repotrectinib, while OATP1A/1B, ABCG2, and CYP3A Limit Its Oral Availability
W Li, RW Sparidans, MC Lebre, JH Beijnen, AH Schinkel |
Pharmaceutics | 2021 |
Endogenous Biomarkers for SLC Transporter-Mediated Drug-Drug Interaction Evaluation
Y Li, Z Talebi, X Chen, A Sparreboom, S Hu |
Molecules (Basel, Switzerland) | 2021 |
Mouse NTCP–Mediated Rosuvastatin Uptake In Vitro and in Slc10a1-Deficient Mice
LE Russell, MK DeGorter, RH Ho, BF Leake, CL Schmerk, SE Mansell, RB Kim |
The AAPS Journal | 2021 |
Development and validation of a LC-MS/MS method for in vivo quantification of meta-iodobenzylguanidine (mIBG)
AJ Quiñones, LM Shireman, J Wang |
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences | 2021 |
First genome-wide association study on rocuronium dose requirements shows association with SLCO1A2
S Ahlström, P Bergman, R Jokela, L Ottensmann, A Ahola-Olli, M Pirinen, KT Olkkola, MA Kaunisto, E Kalso |
British Journal of Anaesthesia | 2021 |
OATP1A/1B, CYP3A, ABCB1, and ABCG2 limit oral availability of the NTRK inhibitor larotrectinib, while ABCB1 and ABCG2 also restrict its brain accumulation
Y Wang, RW Sparidans, W Li, MC Lebre, JH Beijnen, AH Schinkel |
British Journal of Pharmacology | 2020 |
Inhibition of Hepatic Bile Acid Uptake by Myrcludex B Promotes Glucagon-Like Peptide-1 Release and Reduces Obesity
JM Donkers, RL Abbing, M van Weeghel, JH Levels, A Boelen, AH Schinkel, RP Elferink, SF van de Graaf |
CMGH Cellular and Molecular Gastroenterology and Hepatology | 2020 |
Transcriptomic Profiling Identifies Novel Hepatic and Intestinal Genes Following Chronic Plus Binge Ethanol Feeding in Mice
L Jiang, H Chu, B Gao, S Lang, Y Wang, Y Duan, B Schnabl |
Digestive Diseases and Sciences | 2020 |
Characterization of organic anion transporting polypeptide 1b2 knockout rats generated by CRISPR/Cas9: a novel model for drug transport and hyperbilirubinemia disease
X Ma, X Shang, X Qin, J Lu, M Liu, X Wang |
Acta pharmaceutica Sinica. B | 2020 |
The importance of transporters and cell polarization for the evaluation of human stem cell-derived hepatic cells
G Török, Z Erdei, J Lilienberg, Á Apáti, L Homolya, E Laconi |
PloS one | 2020 |
Blocking Sodium‐Taurocholate Cotransporting Polypeptide Stimulates Biliary Cholesterol and Phospholipid Secretion in Mice
RL Abbing, D Slijepcevic, JM Donkers, R Havinga, S Duijst, CC Paulusma, J Kuiper, F Kuipers, AK Groen, RP Elferink, SF Graaf |
Hepatology | 2020 |
Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy—Modulators of Cellular Entry or Pharmacokinetics?
K Brecht, AM Schäfer, HE zu Schwabedissen |
Cancers | 2020 |
Organic Anion Transporting Polypeptides: Emerging Roles in Cancer Pharmacology
RR Schulte, RH Ho |
Molecular pharmacology | 2019 |
Circadian Clock Gene Bmal1 Regulates Bilirubin Detoxification: A Potential Mechanism of Feedback Control of Hyperbilirubinemia
S Wang, Y Lin, Z Zhou, L Gao, Z Yang, F Li, B Wu |
Theranostics | 2019 |
Quantitative Kinetic Models from Intravital Microscopy: A Case Study Using Hepatic Transport
M Tavakoli, K Tsekouras, R Day, KW Dunn, S Pressé |
The Journal of Physical Chemistry B | 2019 |
Hepatocyte peroxisome proliferator-activated receptor α regulates bile acid synthesis and transport
C Xie, S Takahashi, CN Brocker, S He, L Chen, G Xie, K Jang, X Gao, KW Krausz, A Qu, M Levi, FJ Gonzalez |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2019 |
Mechanistic insights into the inhibition of NTCP by myrcludex B
JM Donkers, MD Appelman, SF van de Graaf |
2019 | |
Animal models to study bile acid metabolism
J Li, PA Dawson |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2018 |
Bilirubin in the Liver–Gut Signaling Axis
AR Hamoud, L Weaver, DE Stec, TD Hinds |
Trends in endocrinology and metabolism: TEM | 2018 |
Bile Acid Uptake Transporters as Targets for Therapy
D Slijepcevic, SF van de Graaf |
Digestive Diseases | 2017 |
Sortilin 1 Loss-of-Function Protects Against Cholestatic Liver Injury by Attenuating Hepatic Bile Acid Accumulation in Bile Duct Ligated Mice
J Li, BL Woolbright, W Zhao, Y Wang, D Matye, B Hagenbuch, H Jaeschke, T Li |
Toxicological Sciences | 2017 |
Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice
D Slijepcevic, RL Abbing, T Katafuchi, A Blank, JM Donkers, S Hoppe, DR de Waart, D Tolenaars, JH van der Meer, M Wildenberg, U Beuers, RP Elferink, AH Schinkel, SF van de Graaf |
Hepatology | 2017 |
Constitutive androstane receptor activation promotes bilirubin clearance in a murine model of alcoholic liver disease
X Wang, L Zheng, J Wu, B Tang, M Zhang, D Zhu, X Lin |
Molecular medicine reports | 2017 |
Membrane Transporters for Bilirubin and Its Conjugates: A Systematic Review
J Čvorović, S Passamonti |
Frontiers in pharmacology | 2017 |
Glucuronidation: driving factors and their impact on glucuronide disposition
G Yang, S Ge, R Singh, S Basu, K Shatzer, M Zen, J Liu, Y Tu, C Zhang, J Wei, J Shi, L Zhu, Z Liu, Y Wang, S Gao, M Hu |
Drug Metabolism Reviews | 2017 |
A phosphotyrosine switch regulates organic cation transporters
JA Sprowl, SS Ong, AA Gibson, S Hu, G Du, W Lin, L Li, S Bharill, RA Ness, A Stecula, SM Offer, RB Diasio, AT Nies, M Schwab, G Cavaletti, E Schlatter, G Ciarimboli, JH Schellens, EY Isacoff, A Sali, T Chen, SD Baker, A Sparreboom, N Pabla |
Nature Communications | 2016 |
ATP11C targets basolateral bile salt transporter proteins in mouse central hepatocytes: de Waart, Naik et al
DR de Waart, J Naik, KS Utsunomiya, S Duijst, K Ho-Mok, AR Bolier, J Hiralall, LN Bull, PJ Bosma, RP Elferink, CC Paulusma |
Hepatology | 2016 |
Proteomic Analysis of the Rat Canalicular Membrane Reveals Expression of a Complex System of P4-ATPases in Liver
PM Chaubey, L Hofstetter, B Roschitzki, B Stieger, P Strnad |
PloS one | 2016 |
Contribution of Organic Anion-Transporting Polypeptides 1A/1B to Doxorubicin Uptake and Clearance
HH Lee, BF Leake, RB Kim, RH Ho |
Molecular pharmacology | 2016 |
Contribution of Hepatic Organic Anion-Transporting Polypeptides to Docetaxel Uptake and Clearance
HH Lee, BF Leake, W Teft, RG Tirona, RB Kim, RH Ho |
Molecular cancer therapeutics | 2015 |
Role of Organic Anion-Transporting Polypeptides (OATPs) in Cancer Therapy
N Thakkar, AC Lockhart, W Lee |
The AAPS Journal | 2015 |
Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na + -taurocholate cotransporting polypeptide knockout mice: Liver Biology/Pathobiology
D Slijepcevic, C Kaufman, CG Wichers, EH Gilglioni, FA Lempp, S Duijst, DR de Waart, RP Elferink, W Mier, B Stieger, U Beuers, S Urban, SF van de Graaf |
Hepatology | 2015 |
Hepatocellular Shuttling and Recirculation of Sorafenib-Glucuronide Is Dependent on Abcc2, Abcc3, and Oatp1a/1b
A Vasilyeva, S Durmus, L Li, E Wagenaar, S Hu, AA Gibson, JC Panetta, S Mani, A Sparreboom, SD Baker, AH Schinkel |
Cancer research | 2015 |
Functional expression of the 11 human Organic Anion Transporting Polypeptides in insect cells reveals that sodium fluorescein is a general OATP substrate
I Patik, D Kovacsics, O Német, M Gera, G Várady, B Stieger, B Hagenbuch, G Szakács, C Özvegy-Laczka |
Biochemical Pharmacology | 2015 |
Identification of the Bile Acid Transporter Slco1a6 as a Candidate Gene That Broadly Affects Gene Expression in Mouse Pancreatic Islets
J Tian, MP Keller, AT Oler, ME Rabaglia, KL Schueler, DS Stapleton, AT Broman, W Zhao, C Kendziorski, BS Yandell, B Hagenbuch, KW Broman, AD Attie |
Genetics | 2015 |
Pharmacogenomics in Drug Discovery and Development
Q Yan |
2014 | |
Intestinal transport and metabolism of bile acids
PA Dawson, SJ Karpen |
Journal of lipid research | 2014 |
Quantitative assessment of the multiple processes responsible for bilirubin homeostasis in health and disease
D Levitt, M Levitt |
Clinical and experimental gastroenterology | 2014 |
Differential cellular expression of organic anion transporting peptides OATP1A2 and OATP2B1 in the human retina and brain: implications for carrier-mediated transport of neuropeptides and neurosteriods in the CNS
B Gao, SR Vavricka, PJ Meier, B Stieger |
Pflügers Archiv - European Journal of Physiology | 2014 |
Comprehensive Physiology
AW Wolkoff |
Comprehensive Physiology | 2014 |
What do drug transporters really do?
SK Nigam |
2014 | |
Association of neonatal hyperbilirubinemia in breast-fed infants with UGT1A1 or SLCOs polymorphisms
H Sato, T Uchida, K Toyota, T Nakamura, G Tamiya, M Kanno, T Hashimoto, M Watanabe, K Aoki, K Hayasaka |
Journal of Human Genetics | 2014 |
Comprehensive Physiology
BJ Wilkins, M Pack |
Comprehensive Physiology | 2013 |
Targeting TNF-α and NF-κB Activation by Bee Venom: Role in Suppressing Adjuvant Induced Arthritis and Methotrexate Hepatotoxicity in Rats
SF Darwish, WM El-Bakly, HM Arafa, E El-Demerdash, HM Ashour |
PloS one | 2013 |
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
P Godoy, NJ Hewitt, U Albrecht, ME Andersen, N Ansari, S Bhattacharya, JG Bode, J Bolleyn, C Borner, J Böttger, A Braeuning, RA Budinsky, B Burkhardt, NR Cameron, G Camussi, CS Cho, YJ Choi, JC Rowlands, U Dahmen, G Damm, O Dirsch, MT Donato, J Dong, S Dooley, D Drasdo, R Eakins, KS Ferreira, V Fonsato, J Fraczek, R Gebhardt, A Gibson, M Glanemann, CE Goldring, MJ Gómez-Lechón, GM Groothuis, L Gustavsson, C Guyot, D Hallifax, S Hammad, A Hayward, D Häussinger, C Hellerbrand, P Hewitt, S Hoehme, HG Holzhütter, JB Houston, J Hrach, K Ito, H Jaeschke, V Keitel, JM Kelm, BK Park, C Kordes, GA Kullak-Ublick, EL LeCluyse, P Lu, J Luebke-Wheeler, A Lutz, DJ Maltman, M Matz-Soja, P McMullen, I Merfort, S Messner, C Meyer, J Mwinyi, DJ Naisbitt, AK Nussler, P Olinga, F Pampaloni, J Pi, L Pluta, SA Przyborski, A Ramachandran, V Rogiers, C Rowe, C Schelcher, K Schmich, M Schwarz, B Singh, EH Stelzer, B Stieger, R Stöber, Y Sugiyama, C Tetta, WE Thasler, T Vanhaecke, M Vinken, TS Weiss, A Widera, CG Woods, JJ Xu, KM Yarborough, JG Hengstler |
Archives of Toxicology | 2013 |
Intracellular Drug Concentrations and Transporters: Measurement, Modeling, and Implications for the Liver
X Chu, K Korzekwa, R Elsby, K Fenner, A Galetin, Y Lai, P Matsson, A Moss, S Nagar, GR Rosania, JP Bai, JW Polli, Y Sugiyama, KL Brouwer |
Clinical Pharmacology & Therapeutics | 2013 |
Organic anion-transporting polypeptide 1a4 (Oatp1a4) is important for secondary bile acid metabolism
Y Zhang, IL Csanaky, FP Selwyn, LD Lehman-McKeeman, CD Klaassen |
Biochemical Pharmacology | 2013 |
New insights in bilirubin metabolism and their clinical implications
E Sticova, M Jirsa |
World journal of gastroenterology : WJG | 2013 |
Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters
MS Anwer, B Stieger |
Pflügers Archiv - European Journal of Physiology | 2013 |
Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide
EI Zimmerman, S Hu, JL Roberts, AA Gibson, SJ Orwick, L Li, A Sparreboom, SD Baker |
Clinical cancer research | 2013 |
Modulation of OATP1B-type transporter function alters cellular uptake and disposition of platinum chemotherapeutics
CS Lancaster, JA Sprowl, AL Walker, S Hu, AA Gibson, A Sparreboom |
Molecular cancer therapeutics | 2013 |
Organic anion transporting polypeptide 1B transporters modulate hydroxyurea pharmacokinetics
AL Walker, CS Lancaster, D Finkelstein, RE Ware, A Sparreboom |
American journal of physiology. Cell physiology | 2013 |
Utility of Oatp1a/1b-Knockout and OATP1B1/3-Humanized Mice in the Study of OATP-Mediated Pharmacokinetics and Tissue Distribution: Case Studies with Pravastatin, Atorvastatin, Simvastatin, and Carboxydichlorofluorescein
JW Higgins, JQ Bao, AB Ke, JR Manro, JK Fallon, PC Smith, MJ Zamek-Gliszczynski |
Drug Metabolism and Disposition | 2013 |
Complete OATP1B1 and OATP1B3 deficiency underlies human Rotor syndrome, Oatp1a/1b deficiency underlies its mouse equivalent
Evita van de Steeg, Viktor Stránecký, Hana Hartmannová, Lenka Nosková, Martin Hřebíček, Els Wagenaar, Anita van Esch, Dirk R. de Waart, Ronald Oude Elferink, Kathryn E Kenworthy, Eva Sticová, Mohammad al-Edreesi, A.S. Knisely, Stanislav Kmoch, Milan Jirsa, Alfred Schinkel |
Journal of Clinical Investigation | 2012 |
Organic Anion Transporting Polypeptide 1a1 Null Mice Are Sensitive to Cholestatic Liver Injury
Y Zhang, IL Csanaky, X Cheng, LD Lehman-McKeeman, CD Klaassen |
Toxicological Sciences | 2012 |
Polysome Profiling in Liver Identifies Dynamic Regulation of Endoplasmic Reticulum Translatome by Obesity and Fasting
S Fu, J Fan, J Blanco, A Gimenez-Cassina, NN Danial, SM Watkins, GS Hotamisligil |
PLoS genetics | 2012 |
The SLCO (former SLC21) superfamily of transporters
B Hagenbuch, B Stieger |
Molecular Aspects of Medicine | 2012 |
Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition
LB Ramsey, GH Bruun, W Yang, LR Treviño, S Vattathil, P Scheet, C Cheng, GL Rosner, KM Giacomini, Y Fan, A Sparreboom, TS Mikkelsen, TJ Corydon, CH Pui, WE Evans, MV Relling |
Genome research | 2011 |
Growth hormone–STAT5 regulation of growth, hepatocellular carcinoma, and liver metabolism
M Baik, JH Yu, L Hennighausen |
Annals of the New York Academy of Sciences | 2011 |
Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C
SJ Schrieber, RL Hawke, Z Wen, PC Smith, KR Reddy, AS Wahed, SH Belle, NH Afdhal, VJ Navarro, CM Meyers, E Doo, MW Fried |
Drug metabolism and disposition: the biological fate of chemicals | 2011 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |